{"id":19702,"date":"2026-06-11T18:00:00","date_gmt":"2026-06-11T16:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=d10452b456360cadefdd748997891fd1"},"modified":"2026-06-11T18:00:00","modified_gmt":"2026-06-11T16:00:00","slug":"brightfocus-foundation-launches-lets-talk-alzheimers-podcast-featuring-top-experts-in-alzheimers-research","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=19702","title":{"rendered":"BrightFocus Foundation Launches \u201cLet\u2019s Talk Alzheimer\u2019s\u201d Podcast Featuring Top Experts in Alzheimer\u2019s Research"},"content":{"rendered":"

\nNew podcast features world-class scientists and doctors discussing late-breaking Alzheimer\u2019s and dementia research in plain language for families and caregivers<\/p><\/a><\/a><\/a><\/a>

\nMore than 7 million Americans are living with Alzheimer\u2019s disease, a progressive, terminal brain disorder with no cure<\/p>

CLARKSBURG, Md.--(BUSINESS WIRE)--#Alzheimers<\/a>--Global brain and eye research nonprofit BrightFocus Foundation<\/a> today announced the launch of Let's Talk Alzheimer's<\/i><\/a>, a new podcast that brings insightful, actionable conversations about Alzheimer\u2019s disease and brain health to listeners in an accessible, on-demand audio\/video format. The podcast features content adapted from BrightFocus\u2019 highly popular Zoom In on Dementia & Alzheimer\u2019s<\/i> series, which has garnered over 7 million views to date.<\/p>

\n\u201cFamilies affected by Alzheimer\u2019s disease are seeking clear, trustworthy information they can easily access and understand,\u201d said Stacy Pagos Haller, president and CEO of BrightFocus Foundation. \u201cBy adapting our popular, live Zoom In<\/i> conversations to the podcast format, we\u2019re making these important expert insights available to even more people wherever and whenever they choose to listen.\u201d<\/p>

\nThe first three episodes, released today, explore eligibility and usage information for the FDA-approved disease-modifying treatments Leqembi and Kisunla (Dr. Armen Moughamian, Sutter Health); how to recognize the earliest signs and symptoms of Alzheimer\u2019s (Dr. Sharon Cohen, University of Toronto);<\/span> and how modifying certain lifestyle factors have been proven to substantially improve brain health (Dr. Laura Baker, Wake Forest University School of Medicine). Episodes feature internationally recognized Alzheimer\u2019s researchers, physicians, and clinicians; previous guests have included leading researchers from Washington University in St. Louis, Harvard, Mayo Clinic, and Barrow Neurological Institute.<\/p>

\nNew episodes will be released bi-weekly and available on major podcast platforms, including Spotify<\/a>, Apple Podcasts<\/a>, and YouTube<\/a>.<\/p>

\nLet\u2019s Talk Alzheimer\u2019s <\/i>is hosted by Nancy Keach, senior vice president at BrightFocus Foundation and an award-winning documentary film producer. Episodes cover timely topics such as early diagnosis, treatment options, non-pharmacological interventions, brain health research, active clinical trials, and practical guidance\u2014helping individuals, families, and caregivers make sense of an often overwhelming journey.<\/p>

\n\u201cAlzheimer\u2019s research is advancing rapidly, and there is tremendous interest in understanding what these discoveries mean for individuals and families,\u201d said Haller. \u201cThis podcast helps translate complex science into engaging, approachable conversations people can listen to anytime.\u201d<\/p>

\nTo listen and learn more, visit BrightFocus.org\/LetsTalkAlzheimers<\/a>.<\/p>

\nBrightFocus thanks the sponsors of Let\u2019s Talk Alzheimer\u2019s<\/i> for making this program free and accessible to all: Lilly, Biogen, Eisai, and Genentech.<\/p>

\nBrightFocus Foundation is a leading provider of free educational resources on Alzheimer\u2019s disease<\/a>, macular degeneration<\/a>, and glaucoma<\/a>, reaching millions of individuals each year through trusted health information and public awareness initiatives.<\/p>

\nAmong its signature programs are Zoom In on Dementia & Alzheimer\u2019s<\/i><\/a>, Macular Chats<\/a>, and Glaucoma Chats<\/a>, presented in partnership with the American Glaucoma Society\u2014free monthly discussions featuring leading scientists, physicians, and vision experts. Through expert-led live webinars, podcasts, articles, fact sheets, and community programs, BrightFocus is dedicated to connecting people with timely, evidence-based information and practical guidance to support brain and vision health.<\/p>

\nAbout BrightFocus Foundation\n<\/b>BrightFocus Foundation is a leading global nonprofit funder of brain and eye research. Since its founding more than 50 years ago, BrightFocus and its flagship programs\u2014Alzheimer\u2019s Disease Research, National Glaucoma Research, and Macular Degeneration Research\u2014have invested more than $330 million in groundbreaking research grants, driving breakthroughs in treatments, diagnostics, and risk reduction. Learn more and access the latest research news and resources at brightfocus.org<\/a>.<\/p> Contacts<\/b>

\nJulia S. Roth\njroth@brightfocus.org<\/a><\/p>","protected":false},"excerpt":{"rendered":"

New podcast features world-class scientists and doctors discussing late-breaking Alzheimer\u2019s and dementia research in plain language for families and caregivers
\nMore than 7 million Americans are living with Alzheimer\u2019s disease, a progressive, terminal…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-19702","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/19702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19702"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/19702\/revisions"}],"predecessor-version":[{"id":19703,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/19702\/revisions\/19703"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}